Kristen Fortney serves as Executive at BioAge Labs, Inc., where they oversee executive responsibilities. Since joining the company, Kristen Fortney has executed 1 insider transactions totaling $4.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 13, 2026 involved selling 233,107 shares valued at $4.2M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 13, 2026 | BIOA | $4.2M | Sale | 233,107 | $18.12 | Discretionary |
Kristen Fortney currently holds 976,949 shares of BioAge Labs, Inc. (BIOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristen Fortney has been a net seller of BIOA stock. They have purchased $0 and sold $4.2M worth of shares.
Kristen Fortney's most recent insider trade was on Jan 13, 2026, when they sold 233,107 shares at $18.12 per share.
Get notified when new Form 4 filings are submitted